Synermore Biologics (Suzhou) Co., Ltd.
6 clinical trials · Sponsor
◉ Watch Synermore Biologics (Suzhou) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Real World Evidence Study of SYN023 in Children Exposed to Rabies (NCT07327307) | Synermore Biologics (Suzhou) Co., Ltd. | 2025-08-02 |
| Real-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in Nanyang (NCT07624461) | Synermore Biologics (Suzhou) Co., Ltd. | 2025-06-06 |
| SYN023 With Rabies Vaccine in Healthy Pediatric Subjects (NCT07342257) | Synermore Biologics (Suzhou) Co., Ltd. | 2024-11-30 |
| A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety (NCT04644484) | Synermore Biologics (Suzhou) Co., Ltd. | 2020-09-23 |
| A Bridging Study of the SYN023 on Healthy Adult Subjects (NCT04495569) | Synermore Biologics (Suzhou) Co., Ltd. | 2019-02-26 |
Track Synermore Biologics (Suzhou) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.